Anti-Infectives
Linezolid
Linezolid 200 mg/100ml - 100ml Vial
Therapeutic Indications :
Linezolid is indicated for the treatment of community-acquired pneumonia and nosocomial
pneumonia when known or suspected to be caused by susceptible Gram-positive bacteria.
In determining whether Linezolid is an appropriate treatment, the results of microbiological
tests or information on the prevalence of resistance to antibacterial agents among Gram-positive bacteria should be taken into consideration.
Linezolid is not active against infections caused by Gram-negative pathogens.
Complicated skin and soft tissue infections.
Linezolid is indicated for the treatment of complicated skin and soft tissue infections only
when microbiological testing has established that the infection is known to be caused by susceptible Gram-positive bacteria.
Linezolid is not active against infections caused by Gram-negative pathogens.
Linezolid should only be used in patients with complicated skin and soft tissue infections with
known or possible co-infection with Gram-negative organisms if there are no alternative
treatment options available.